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Lung disease accounts for every sixth death globally. Profiling the molecular state of all lung cell types in                  
health and disease is currently revolutionizing the identification of disease mechanisms and will aid the               
design of novel diagnostic and personalized therapeutic regimens. ​Recent progress in high-throughput            
techniques for single-cell genomic and transcriptomic analyses has opened up new possibilities to study              
individual cells within a tissue, classify these into cell types, and characterize variations in their               
molecular profiles as a function of genetics, environment, cell-cell interactions, developmental           
processes, ageing or disease. Integration of these cell state definitions with spatial information allows              
the in-depth molecular description of cellular neighborhoods and tissue microenvironments including           
the tissue resident structural and immune cells, the tissue matrix as well as the microbiome. The Human                 
Cell Atlas consortium aims to characterize all cells in the healthy human body, ​and has prioritized lung                 
tissue as ​one of the flagship projects. Here, we present the rationale, the approach and the expected                 
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Rationale for a Human Lung Cell Atlas 
Lung disease is a leading cause of mortality in the US and worldwide, with more than 7 million deaths                   
attributed to lung disease annually ​(1)​. ​Although the lung has been reported to harbor at least 40                 
discrete cell types ​(2)​, the recent identification of the ionocyte as a novel epithelial cell type in human                  
airway wall (See Boxed item 1) shows that our knowledge of the cells in human lung is incomplete ​(3, 4)​.                    
Therefore, further studies to systematically and comprehensively characterize all cell types in human             
lung tissue, and the changes in cellular composition and function associated with initiation, progression              
and resolution of human lung disease are urgently needed. 
  
The cell is the fundamental unit of all living organisms ​(5)​. The cumulative function of all cells and their                   
interactions with each other and with non-cellular tissue components determines the physiology of any              
tissue or organ. Disease is believed to be a consequence of cell intrinsic changes, changes in response to                  
environmental insults, altered cell-cell communication, disbalance of cell type proportions and/or           
perturbed architecture of tissues. Recent progress in single-cell analyses and accompanying           
computational methodologies, provides an extraordinary opportunity to characterize individual cells and           
their spatial organization on the basis of their RNA or protein expression profile, allowing ​de novo                
classification of cell types and a comprehensive description of their dynamic phenotype. Combining             
these with rapidly evolving spatially resolving methods for the analysis of DNA, RNA or protein profiles                
allows the interpretation or annotation of the cellular heterogeneity in a tissue context.  
 
The Human Cell Atlas (HCA) Consortium is an international, collaborative effort aiming to define all               
human cell types in terms of their distinctive patterns of gene expression, physiological states,              
developmental trajectories, and spatial relationships in tissue ​(6)​. As part of this overarching effort, we               
intend to build a comprehensive atlas of human lung in a staged and integrated approach. Molecular                
profiles of single cells will be mapped computationally on a common coordinate framework of the entire                
organ in relation to spatial landmarks of both micro- and macro-anatomy, starting from the histological               
structure of cell neighborhoods, building up layers of increasingly larger units of spatial organization, up               
to the full organ. 
  
The Lung Cell Atlas will reveal unprecedented insights about the identities, activities and lineage              
relationships of all cells in healthy human lung, enabling the modeling of lung homeostatic circuitry ​(6)​.                
The Lung Cell Atlas will then serve as a reference point for the analysis of diseased lung tissue at                   
single-cell resolution and will allow identification of the shifts in cellular repertoire, the changes in               
cellular states and phenotypes, and the altered cell-cell interactions that disrupt normal lung             
homeostasis and constitute disease. Comparing lung disease data with the lung development reference             
within the Human Lung Cell Atlas, may reveal whether cellular changes in certain chronic lung diseases                
represent a failed recapitulation of organogenesis or the acquisition of entirely new pathologic programs              
governing cell fate and behavior. Thus, the generation of a high resolution, comprehensive catalogue of               
the changes in lung cellular composition and function in health and disease is expected to lead to                 
development of novel cell and disease specific biomarkers and advancements in therapeutic strategies             
for lung disease.  
  
Cellular and Anatomical Complexity of the Human Lung 
The primary function of lung tissue - gas exchange between the body and its environment - is dependent                  
on a specialized anatomy involving numerous distinct epithelial and endothelial cell populations,            
supported by specific tissue-resident leukocyte populations, and various mesenchymal cell types           
providing structural support. The unique anatomy of the lung is established during development by              
branching morphogenesis resulting in a tree of airways and alveoli, mirrored with trees of blood and                
lymphatic vessels. Air flows from the nasal cavity into the conducting airways, involving trachea and the                
main bronchi, which iteratively bifurcate into the branching bronchial tree. The human trachea and              
airways are composed of a pseudostratified epithelium on the luminal side, with a basal lamina lined                
with mesenchyme, cartilage, smooth muscle, blood vessels, immune cells and other rare cell types ​(7)​.               
The airways end in terminal bronchioles, which then lead into composite respiratory units including the               
respiratory bronchioles, the alveolar duct and the alveolar sac, where gas exchange occurs ​(7)​. The               
airways serve as a conduit for gases from the atmosphere to the alveoli, but also have a role in filtering                    
the inhaled air for solid particles and removing these in a process called mucociliary clearance, thereby                
protecting the distal saccular structures of the alveoli. Gas exchange happens in the alveolar unit,               
featuring ultra-thin type-1 pneumocytes wrapped by a layer of capillaries, supported by interstitial cells              
such as matrix producing fibroblasts and the pulmonary surfactant layer ​(8)​. Type-2 pneumocytes             
produce and secrete surfactant, maintain the fluid balance of the alveolar unit and serve as local                
facultative progenitor cells for type-1 cells ​(9–11)​. Resident immune cells, particularly alveolar            
macrophages and peribronchial and perivascular “interstitial” macrophages play important roles in           
orchestration of the immune response and in the maintenance of lung homeostasis ​(12, 13)​. Alveolar               
macrophages and alveolar epithelial cells express reciprocal sets of ligands and receptors, which prevent              
an excessive inflammatory response to inhaled particles. Several studies in mice have demonstrated that              
peribronchial macrophages consist of multiple ontologically and anatomically distinct subsets ​(14)​,           
however, little is known about their human counterparts.   
 
Single-cell molecular studies profiled from a comprehensive sampling of human lungs will empower the              
mapping of all possible cellular identities (or states) onto a framework of a high dimensional phenotypic                
cellular (gene and protein expression) landscape. Such a phenotypic landscape will describe cell type              
identity as stable intermediates within a continuum of possible states, including lineage relationships             
and potential transitory paths between different states. ​The power of his approach is elegantly shown in                
a recent review on the cellular and molecular pathways involved in lung organogenesis, where single-cell               
datasets from mouse lung development are used to identify and map cellular trajectories during the               
different stages of organogenesis ​(15)​. The exciting recent demonstration of genetic lineage tracing in              
human tissues employing mtDNA mutations will now also enable the combination of lineage inference              
with gene expression or chromatin state profiles in human tissues ​(16)​. Thus, the use of mtDNA                
mutations as natural genetic barcodes may reveal the clonal architecture in human lung health and               
disease. ​The multiple snapshots of molecular identities present along the high-dimensional gene            
expression landscape can also result in the molecular description of unknown cellular states, which may               
have functions distinct from the traditional cell type definitions currently recognized. Similarly, we will              
likely encounter gradients of cellular phenotypes along spatial trajectories, as these `specialized´ cellular             
states are driven by their microenvironment, as was recently reported for enterocytes in the mouse               
intestine ​(17)​.  
 
All lung cells are contained within a regionally tailored and highly complex extracellular matrix that               
forms the basis of various distinct microenvironments, which is further defined by (the signals from)               
other cells in close proximity and potentially local variations in the microbiome. The effect of the                
microenvironment on the molecular phenotype of a cell has not been explored into great detail,               
although diseased human lung extracellular matrix, for instance, has been shown to drive a specific               
cellular transcriptome ​(18)​. Whether the identity of cells within the lung is determined by their specific                
location ​and function within the tissue and local microenvironment or by their developmental origin, or               
by a combination of both, is one of the key questions for the Human Lung Cell Atlas. Interestingly, it was                    
recently reported that distinct developmental lineages can produce the same anatomical cell type by              
converging to a homogenous transcriptomic state in the final cell divisions of development, indicating              
that distinct developmental lineages can assume very similar molecular phenotypes as a function of              
their local niche ​(19)​. Location-dependent variation in the (molecular) state of cells in human lung has                
not been studied in detail yet, although in the mouse model, club cells have been shown to have a                   
transcriptomic phenotype that is dependent on their position along the respiratory tract ​(3)​. The relative               
frequency of epithelial airway cell types varies along the respiratory tract ​(20)​. Submucosal glands are               
present from trachea to the small airways in human lung, but whether their composition is constant                
along the respiratory tract remains to be established. Similarly, it is unknown whether location within               
the lung affects the molecular phenotype of the cells that make up the alveolar unit. A unique feature of                   
the lung is that it is a constantly moving organ, with dynamic changes in pressure and shape leading to                   
presumably similar cells being exposed to very distinct mechanical cues – apical versus basal, central               
versus peripheral - and the cellular transcriptomic adaptations to these variables are completely             
unknown.  
  
A complete atlas of the healthy human lung must sample the entire coordinate framework of the organ,                 
both macro- and micro-anatomically, and capture the natural variation of cellular states within the              
healthy population (See Boxed item 2). A comprehensive map of molecular cell states and the possible                
transitions between them will provide mechanistic insight into developmental processes and           
regenerative and repair capacity in the lung and their underlying regulatory mechanisms. The Human              
Lung Cell Atlas will map this landscape of molecular cell states onto a framework of spatial landmarks                 
and enable the direct comparison of samples between multiple healthy and, eventually, diseased             
individuals.  
  
A Cellular Reference Map of Human Lung Development 
The process of building the lung structure, and maturing the cells it contains, occurs over many weeks of                  
embryonic development and beyond in humans and is thought to require numerous different cell-cell              
and cell-matrix interactions ​(15, 21)​. Many of these signaling and physical interactions occur between              
multiple progenitor cell types which are specific to a developmental time window and do not exist in the                  
adult organ. The epithelium is the best-characterized part of the developing lung and at least three,                
apparently embryonic-specific, progenitor cell types have been detected. For example, the budding tip             
of the developing human lung epithelium was shown to be analogous to that of the mouse and contain a                   
major epithelial progenitor population required during branching morphogenesis ​(22, 23)​. However,           
there is no evidence that such cells exist in the mature lung. Characterization of the               
development-specific, or possibly developmentally-enriched, progenitor cell states, and their         
(developmental) trajectories in the transcriptomic landscape, within the Human Cell Atlas Project will             
first and foremost provide insight into the basic mechanisms of lung development. In addition, it will                
provide specific and critical data allowing long-standing hypotheses regarding the recapitulation of            
developmental mechanisms in repair and disease states to be tested. ​While the initial focus of the                
Human Lung Cell Atlas is on adult lung, it will integrate data from the Pediatric Cell Atlas ​(24) and                   
initiatives focused on lung development, such as LungMAP or the recent NIH-funded DEVMAP. 
  
Due to the progressive nature of branching morphogenesis, the developing lung epithelium contains a              
continuum of cells along the proximal-distal axis in progressive states of maturity from multipotent              
progenitor to fully mature mucocilliary, or alveolar, epithelium. This is particularly significant given the              
low rates of cell turn-over in the adult organ ​(25) and means that analysis of embryonic lung                 
development will allow states of differentiation, particularly intermediate forms, to be analyzed            
transcriptionally in a way that will be very difficult in the adult lung. In addition, the developing human                  
lung mesenchymal and leukocyte cell lineages are almost completely uncharacterized. For example, it is              
unknown when artery-venous fate arises in the lung endothelium, or when alveolar macrophages first              
become resident in the human lungs. A Developmental Lung Cell Atlas will provide baseline data               
describing the molecular phenotype of the cells in developing lung, facilitating their future functional              
characterization. It is important to note that the human lung continues to grow after birth well into                 
puberty and beyond. While the cellular changes during this period are completely unknown, they are               
considered to be of critical importance to development of lung disease later in life ​(26)​. The presence of                  
bronchial associated lymphoid tissue (BALT) is rarely observed during fetal lung development and             
infrequently in newborns and infants in the absence of infection ​(27)​, has been reported to increase                
with age during the first few years of life ​(28, 29)​, and absent in healthy adults after the age of 20 ​(30)                      
except in the context of specific inflammatory conditions ​(31)​. This illustrates the intimate interactions              
between a developing immune system, environmental challenges and a maturing lung during early life,              
further emphasizing the need for inclusion of neonatal and pediatric studies in the Human Lung Cell                
Atlas. 
  
The Human Lung Cell Atlas of healthy ageing and disease 
The ageing process manifests itself in age-related changes in body composition, the endocrine system              
and vasculature, which are initially subclinical ​(32)​. The lung grows progressively until early adulthood,              
and lung function peaks between 18 and 25 years of age. After this peak, lung function declines,                 
associated with structural remodeling of the lung, progressive loss of alveolar surface area and              
enlargement of alveolar size ​(33, 34)​. In addition, mucociliary clearance is reduced with age in both                
upper and lower airways ​(35, 36)​. At the cellular level, hallmarks of ageing include genomic instability,                
telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing          
mitochondrial dysfunction, stem cell exhaustion, cellular senescence and altered cell-cell          
communication ​(37)​, which is reflected in (bulk) gene expression patterns from lung ​(38)​. Cellular              
senescence contributes to alterations in extracellular matrix and is associated with physiological            
remodeling of the ageing lung ​(39)​, and mitochondrial dysfunction has been observed in age-related              
lung disorders, including COPD and IPF ​(40)​. Integrating deep tissue proteomics and single cell              
transcriptomics, a first draft of an aging mouse lung atlas reported increased transcriptional noise,              
indicating loss of epigenetic control ​(41)​. Furthermore, age associated changes in composition of the              
extracellular matrix, ciliated cell frequency and a pro-inflammatory microenvironment were evident in            
both proteome and transcriptome ​(41)​.  
 
To systematically and comprehensively analyze the effect of age on human lung cells, tissue sources               
used for the Human Lung Cell Atlas should therefore be collected over the entire adult age range from                  
20 – 80 years old. To distinguish natural variation from sub-clinical disease and to incorporate a history                 
of relevant environmental and infectious exposures we will need to obtain detailed clinical data, and               
potentially need to use biological characteristics of aging such telomere length ​(42) and the epigenetic               
clock ​(43) to calibrate the findings and understand natural variation and boundaries of health and               
disease. The promise of single cell molecular profiling is to deliver unprecedented insight into the               
cellular origins of human disease. The human genome project and decades of genomic research have               
enabled investigations into the association of gene polymorphisms with disease. Using single cell             
transcriptomics we can now move from genetic and genomic associations to more mechanistic             
questions about disease and cell type associated gene networks and reveal the cellular context of               
disease associated polymorphisms ​(44)​. 
  
The approach of the Human Lung Cell Atlas: Toolbox and Resources 
  
Single cell transcriptomics 
Single cell RNA sequencing (scRNA-seq) aims to comprehensively capture and sequence the RNA             
contents of a single cell, allowing a description of transcriptional heterogeneity in cell populations.              
Stable transcriptional phenotypes can be contrasted with differentiation trajectories of cells by inferring             
an ordered sequence of transcriptional states in pseudotime. The key to the utility of scRNA-seq in tissue                 
profiling has been the massive increase from 10’s to over 100,000 cells per experiment in less than a                  
decade ​(45, 46)​, due to technological advances as recently reviewed ​(47)​. Comprehensive profiling of a               
tissue under specific (developmental, diseased) conditions requires a high throughput, capturing all cell             
types and states - including putative novel ones - at a threshold of sensitivity that is determined by both                   
cell input and the observed variation in transcriptional profiles between discrete cell states. Rare cell               
types with a transcriptional phenotype that is not sufficiently discrete can be missed in unsupervised               
clustering, as exemplified by the neuroendocrine cells in the recent cell census of airway wall tissue ​(48)​.                 
Although enrichment or purification of these cell types prior to scRNA-Seq analysis can be applied, this                
does require prior knowledge of their identity. Atlasing studies therefore often combine a high              
throughput approach for cell type and cell marker identification with in depth profiling of purified               
subpopulations of special interest. ​To assess completeness of the single cell sampling ​in silico bulk               
profiles from scRNA-seq can be compared to true bulk RNA-seq data generated from adjacent regions of                
tissue. Another attractive alternative is the use of new high-density spatial transcriptomic tools, such as               
Slide-seq or HDST ​(49, 50)​. These spatial tools can identify the microanatomical niches that are               
systematically undersampled and guide efforts for targeted enrichment.  
  
Currently, sequencing of single cells from freshly dissociated tissue yields the greatest number of genes               
identified per cell. However, this comes at the cost of introducing potential dissociation biases, such as a                 
stress response induced by enzymatic tissue digestion ​(51) or a bias in cell type composition as cell types                  
differ in their optimal conditions for release from the tissue ​(52, 53)​. An alternative technique is the                 
isolation of nuclei from snap-frozen tissue, which are then assayed by single nuclear RNAseq protocols               
(snRNA-seq). In general, snRNA-seq can be performed on cryostat sections of lung tissue, with the               
advantage of improved tissue processing with less biased isolation, and enabling profiling of adjacent              
tissue or serial sections using targeted imaging techniques in order to put the snRNA-seq data into                
spatial context ​(49, 50, 54–57)​. While single nucleus RNA-seq detects less genes and unique transcripts,               
than scRNA-seq it allows the use of archived samples ​(58–61)​. On the whole, scRNAseq and snRNAseq                
data correlate well ​(62) and allow robust cell type identification as well as the derivation of                
developmental trajectories for the different cell types present in a tissue.  
  
Beyond single cell transcriptomics 
While much of single cell biology has focused on the transcriptome, epigenetic profiling of single cells                
can provide information on a cells’ past history and potential future states. Of the various epigenetic                
profiling methods available, ATAC (Assay for Transposase-Accessible Chromatin)-seq uses transposase          
tagging to identify regions of open chromatin and regulatory elements within the genome. Recently,              
single cell ATAC-Seq has become available with the development of upfront bulk tagmentation, followed              
by DNA fragmentation at the single cell level ​(63, 64)​. scATAC-seq has been shown to provide                
mechanistic insight into the regulatory mechanisms underlying cell states and their transitions ​(65)​.             
Differentiation trajectories of blood cells detected with scATAC-Seq were similar to those from RNA but               
with earlier branching points, reflecting that the chromatin changes detected by ATAC accessibility             
precedes expression at the RNA level ​(66)​. Thus, scATACseq and scRNA-Seq will provide complementary              
insights into lung cell states and the trajectories between them. As the cost of high throughput scATAC                 
protocols continues to reduce ​(67)​, we expect that this approach will contribute greatly to our               
understanding of lung development, cell type specification and abnormality in disease. 
  
Additional single-cell ‘omics’ approaches, such as genome, methylome, proteome, metabolome, are           
becoming available to complement transcriptomic measurements ​(68)​. The true size and shape of the              
cellular phenotypic landscape of any organ will only be revealed in a multi-omic description of the cells                 
and the non-cellular components. Several multi-omics single-cell approaches have been explored,           
including integrated single-cell measurement of chromatin accessibility, DNA methylation and          
transcriptome ​(69)​, integrated genetic, epigenetic and transcriptomic measurement ​(70)​, and recently           
integrated scRNA-seq with genotype data to discover cell type-specific expression quantitative trait loci             
(eQTLs) ​(71)​. Recent progress in single cell profiling technologies has made it possible to measure               
protein and RNA levels within the same cell simultaneously ​(72–74)​, which enhances discovery of subtle               
cellular phenotypes, such as cell type subpopulations ​(75)​.  
  
Imaging and spatial transciptomics 
Despite the advance of single cell profiling, the function of individual cells within a tissue ultimately                
depends on their location within the tissue architecture, and their interactions with the extracellular              
matrix and neighboring cells. Considering the morphological diversity of the lung, characterization of the              
exact location and local microenvironment where cells are obtained from is critically important.             
Techniques for measuring gene expression within lung tissue context range from spatial transcriptomics,             
microdissection approaches, such as laser-capture microdissection, and ​in situ RNA hybridization to ​in             
situ RNA sequencing. The main limitations on spatial mapping of cell states defined by high dimensional                
gene expression patterns, however, are the number of genes detected on the same tissue sample, and                
the shift from targeted to unbiased detection of gene expression. ​Spatial transcriptomic approaches             
measure gene expression in small voxels of tissue, with recent HDST and Slide-Seq technologies bringing               
the resolution down to around 1-10 𝜇m ​(49, 50)​. A single-molecule fluorescent ​in situ hybridization               
(smFISH)-based protocol to achieve high throughput is the multiplexed error-robust FISH (or MERFISH)             
technology ​(76)​, although application to the lung tissue might require further optimization ​(77)​. Another              
protocol suitable for multiplexed RNA species detection is the proximity ligation and in situ hybridization               
(PLISH) technology ​(78)​. Interestingly, PLISH is compatible with immunohistochemical applications and           
the usage of antibodies on archived (FFPE) tissue. Similarly, detection of proteins and their              
posttranslational modification with antibodies in combination with mRNA transcripts in tissue sections            
was also achieved using a mass cytometric approach ​(79)​. Finally, ​in situ RNA sequencing using padlock                
probes ​(77, 80) or FISSEQ (fluorescent ​in situ RNA sequencing) technology ​(81) is of interest. The                
recently developed STARmap method combined ​in situ amplification of mRNA transcripts with hydrogel             
tissue chemistry, allowing detection of around a thousand genes in millimeter scale tissue blocks after               
clearing of cells and lipids, whilst retaining relative location within the tissue blocks’ coordinate system               
(82)​. Integration of such methods with high-resolution transcriptomic single-cell profiling of matched            
tissue will likely be key to establish a true atlas of the cellular landscape of healthy or diseased human                   
lung. A final technological challenge is to integrate proteomic data and transcriptomic data from single               
cells, which requires development of proteomic methods with single cell sensitivity. Currently, a             
combination of antibody labeling technologies or multi-omics approaches such as combining CyTOF with             
spatially resolving FISH methodologies remains the approach of choice. 
  
Sources of lung tissue 
Lung tissue for the Human Lung Cell Atlas is typically received from (routine) surgical resections, biopsy                
extraction in routine clinical care or in a research setting when involving healthy volunteers or lung                
transplantation programs. In this context, it important to highlight the difficulty of obtaining normal lung               
parenchyma. The most common sources for lung parenchyma are either uninvolved edges of lung              
resections (mostly for cancer) or tissue obtained from deceased donors through organ procurement             
organizations which all can be archived or processed fresh. Common sources of archived lung tissue are                
large tissue banks and repositories that have been established in many centers, mostly associated with               
academic, medical, or governmental organizations ​(83)​. Biobanks or core tissue facilities take care of              
patient information, obtain informed written consent for tissue donations and biopsy collections, and             
process and store tissue in an appropriate manner. They organize and monitor tissue distribution for               
scientific research and store relevant clinical information with respect to preserving patient anonymity,             
and provide centralized data storage. Specimens are collected according to site-specific protocols and             
legal regulations. To minimize tissue collection variability between different centers, common standard            
principles for tissue processing and collection are being developed. Live tissue from bronchoscopic             
biopsies, organ procurement organizations or surgical resection needs special attention after collection.            
These specimens need to be transported immediately after acquisition to the research site for              
preparation of single cell suspensions and downstream processing. Protocols for acquisition, transport            
and processing of fresh tissue samples are harmonized between the HCA Lung working group members,               
and available through online platforms ​(such as: ​https://www.protocols.io/groups/hca/publications​). 
  
Computational challenges 
The number of observations in a typical single cell experiment is generally much larger compared to bulk                 
RNA-seq data. Therefore, the underlying gene expression matrices, often encoded with genes as rows              
and cells as columns, pose novel and complex computational challenges due to their size. Moreover, so                
called dropout events, in which an expressed gene is simply not detected due to lack of sensitivity,                 
introduce high levels of sparsity into the data. Thirdly, the increased resolution enables more precise               
capture of biological heterogeneity which in turn leads to increased complexity in the data. Altogether               
scalability, sparsity and complexity in single cell data pose major challenges when analyzing single cell               
expression profiles. 
Some popular scRNA-seq analysis frameworks such as Scanpy ​(84) are designed to provide high              
scalability. Moreover, dimension reduction applications in molecular biology have evolved with the            
increased size and complexity of single cell data. Linear dimension reduction by principal component              
analysis is commonly used for the visualization of bulk and initial scRNA-seq data sets. More recent                
approaches, using nonlinear two dimensional embeddings such as t-distributed stochastic neighbour           
embedding (t-SNE) and uniform manifold approximation and projection (UMAP), have helped visualize            
single cell data, and have recently been discussed with respect to quality as well as scalability ​(85, 86)​.                  
These nonlinear approaches are particularly suitable for highly complex tissues, such as the lung, where               
a large number of different cell types exist ​(41, 53)​. 
The increased number of cells profiled in a single experiment represents a computational challenge but               
also an opportunity for the application of more sophisticated modeling approaches, including machine             
learning ​(46)​. Deep learning, a subfield of machine learning which has for instance revolutionized image               
analysis, is particularly powerful when large training data sets exist ​(87)​. Some of the recent, larger data                 
sets now open up the possibility to apply deep learning methods to scRNA-seq data. First deep learning                 
algorithms have been developed and tailored towards scRNA-seq data with, for example, the goal of               
denoising scRNA-seq expression data ​(88)​. Machine learning approaches could be very useful for the              
detection of robust cell type-specific signatures and the integration of datasets generated on different              
platforms, where sequencing depth and transcript capture bias can vary dramatically depending on the              
protocol and experimental setup. As more data becomes available and datasets grow in size we               
anticipate to see more machine learning applications for the analysis of scRNA-seq data.  
Unbiased clustering approaches can be applied not only to scRNA-seq or scATAC-seq data, but also to                
spatial techniques to uncover interactions between the cell types forming lung micro-niches, as was              
recently demonstrated for epithelial and mesenchymal cells ​(10, 78, 89)​. These tools will be particularly               
helpful for integration of high throughput sequencing and spatial datasets. In combination with neural              
network based approaches we expect that additional data features such as morphometry - which can for                
example be used to robustly predict cell cycle stage ​(90) - will be integrated into spatial analysis to learn                   
about combined cell state and communication. 
Another promising computational approach is the statistical deconvolution of bulk RNA-seq data using             
scRNA-seq data to infer cell type proportions of a complex tissue sample (measured with bulk RNA-Seq)                
by leveraging information from scRNA-seq data ​(91)​. It was recently shown in pancreatic datasets that               
celltype heterogeneity represents a major covariate in bulk differential expression analysis ​(92)​. Lung             
tissue biopsies can show very high celltype heterogeneity depending on the precise location of surgery               
(93)​. Therefore, publicly available lung bulk data from patients and controls is a particularly promising               
candidate for re-analysis using deconvolution techniques.  
 
Opportunities to build a Human Lung Cell Atlas 
The opportunity to build a high resolution single cell and spatial atlas of the human body has generated                  
enormous excitement in the scientific community. The global initiative to build the Human Cell Atlas,               
launched in 2016, now involves scientists from 62 countries, a number likely to increase. The HCA                
community is supported by many funding organizations and initiatives, and organized into biological             
networks, including the Human Lung Cell Atlas. For example, in the specific area of the lung, the NIH has                   
actively supported these efforts through programs including LungMAP ​(94) in the healthy lung, and              
disease-focused programs, in particular the Cancer Moonshot Human Tumor Atlas Network           
(​http://bit.ly/NCI-HumanTumorAtlas​). Moreover, recognizing these emerging initiatives, and the        
importance of supporting this ambitious new vision, the NIH Common Fund recently launched the              
Human BioMolecular Atlas Program (HuBMAP), which includes the lung among its organs of focus              
(​https://commonfund.nih.gov/hubmap​). Other relevant efforts are supported by the MRC         
(​http://bit.ly/HCALungMRC​) and Wellcome Trust (​http://bit.ly/HCALungW ​) in the UK, and by the Chan            
Zuckerberg Initiative (​http://bit.ly/HCALungCZI1​). The Human Lung Cell Atlas will be built by integration             
of the datasets provided by these and other initiatives. Working within the HCA thus ensures integration                
and international coordination across multiple funded efforts. Indeed, the HCA design is inherently             
inclusive and open, allowing parallel initiatives to contribute to the Human Cell Atlas, leveraging              
expertise, data and technological developments between projects, organ systems, institutes and           
countries. Consequently, the infrastructure that is under development within the HCA consortium will             
have a scope and reach beyond any of the organ-specific atlases, making the HCA well-suited for a truly                  
community-wide effort towards establishing a Human Cell Atlas.  
 
Next steps towards establishing a Human Lung Cell Atlas 
The first cell censi of upper airways and lung tissue have been published ​(48, 53, 95, 96)​, and more will                    
follow with better coverage of regional differences and rare cell types, as evident from the progress                
meetings at the HCA meetings (​http://bit.ly/HCALungTV1​, ​http://bit.ly/HCALungTV2​). These studies on          
single-cell profiling of healthy and diseased lung tissue mainly report scRNA-Seq and ATAC-Seq data ​(48,               
53, 95, 96)​. With the anticipated increase in studies reporting molecular phenotypes of lung cells, the                
efforts of the Lung Biological Network within the HCA consortium is rapidly shifting from reporting on                
the progress of individual groups to coordinating shared and integrated analysis of the cumulative data               
within the HCA data coordination platform (DCP). The next breakthrough in establishing a Human Lung               
Cell Atlas will also come from a detailed spatial mapping of cell types onto the tissue architecture, the                  
description of molecular cell states as a function of relative position in the lung along one of the many                   
gradients present in the tissue or as a function of local cellular neighborhood, and the visualization of                 
the cellular profiles in a spatial framework reflecting the structure of the lung. In addition, novel                
technological advances, especially in spatial mapping and computational approaches (e.g. towards           
multimodal data integration and combined visualization of profiling and spatial data) will remain an              
important topic for future meetings of the Human Cell Atlas consortium.  
 
Joining the HCA Lung Biological Network 
The HCA consortium is open for anyone in the respiratory community to join             
(​https://www.humancellatlas.org/joinHCA ​), and open sharing of best practices and proven productive          
approaches to tissue acquisition, processing, data generation and analysis as well as technological             
innovations will help bring the field forward. Progress will be presented at the HCA meetings, but also at                  
the annual meetings of the American Thoracic Society (ATS) and the European Respiratory Society (ERS).               
Lung has been identified as one of the 12 priority organs and systems within the HCA initiative, with an                   
initial focus on upper and lower airways as well as lung parenchyma ​(6)​. ​To achieve our ambition of                  
establishing the Human Lung Cell Atlas, we call on widespread involvement of the respiratory              
community to contribute to this effort. ​This will allow the HCA-Lung Biological Network ​to achieve the                
depth and breadth necessary to obtain a meaningful reference for basic, translational and clinical              
respiratory scientists and which may serve as an example for other, less readily accessible organ systems                
within the HCA. To facilitate integration of datasets acquired by different research groups at              
geographically distinct sites, in multiple ethnicities, age groups, and genders, we urgently need             
standardization in tissue procurement, processing, and storage, as well as in data generation, handling,              
storage and analysis pipelines. For tissue acquisition, we have developed a series of standardized              
protocols specifically tested and validated for lung tissue, and continue to expand these, ​making them               
available to the community through open access platforms such as protocols.io (See            
https://www.protocols.io/groups/hca/publications​). For processing and integration of data originating        
from multiple centers and divergent technological platforms, methodologies are being tested using the             
datasets from the initial lung scRNA-Seq efforts. ​The computational approaches are also shared with the               
community, for instance through platforms such as Github (​https://github.com/HumanCellAtlas​).         
Methods for integration of genomic, transcriptomic and proteomic datasets from the cellular branch of              
the Human Lung Cell Atlas with those acquired in the spatial branch will need to be further developed.                  
For data storage and accessibility, the HCA-Lung project will tap into ​the HCA data coordination platform                
(DCP) infrastructure that is currently in beta testing. One critical aspect for the Human Lung Cell Atlas to                  
achieve its full impact will be the development of an interactive, tertiary HCA data portals ​(6)​, that allow                  
exploration of the data by the respiratory and single-cell community. At this moment, interim data               
portals allow visualization and limited exploration of the currently available datasets (see for instance              
http://bit.ly/LungMap-scRNASeq ​(94)​; ​https://lungcellatlas.org ​(48)​;    
https://theislab.github.io/LungAgingAtlas ​(41)​, and ​https://www.nupulmonary.org/resources/ ​(53)​).     
Incorporation of detailed demographic and clinical metadata from each tissue source in the HCA data               
coordination portal will be critical to allow the identification of individual and combined contributions of               
gender, ethnicity, age, respiratory health and disease to the position of each cell type in the                
transcriptomic and proteomic landscape that defines the Human Lung Cell Atlas. 
  
The Human Lung cell atlas holds the promise of becoming a resource of unsurpassed scale and detail,                 
allowing the respiratory community to acquire novel insights into the biology of the lung, including - but                 
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Boxed item 1 / Discovery of pulmonary ionocytes: 
Members of the HCA initiative recently led an investigation to characterize the diversity of epithelial               
cells that line the airways of the lung​(3)​. In addition to finding an unexpected diversity of club, tuft, and                   
goblet cells in the murine airway, they also identified a new airway epithelial cell type. This novel cell                  
type specifically expresses the transcription factor Foxi1 and its composite gene expression profile             
resembles those of specialized ion transporting cells in fish gills, frog skin, and mammalian kidney. These                
diverse cell types are collectively referred to as ionocytes, and thus the new pulmonary cell type has                 
been coined a ‘pulmonary ionocyte’. Surprisingly, these cells also expressed the majority of the cystic               
fibrosis transmembrane conductance regulator (Cftr), whose mutation causes Cystic Fibrosis (CF). The            
investigators found that deletion of Foxi1 in mice resulted in the loss of mature ionocytes and                
significantly altered mucus viscosity. They also found that FOXI1​+ pulmonary ionocytes line the airways              
of human lungs, and that human pulmonary ionocytes also are high expressors of CFTR. Their role in ion                  
transport, regulation of mucus, and high CFTR expression collectively suggests that pulmonary ionocytes             
play a critical role in CF biology and disease. 
Figure 1. Pulmonary ionocytes line the epithelium of large airways of human lungs, uniquely express the 
transcription factor FOXI1, and more highly express CFTR than any other cell type in the lung. 
Boxed item 2 / From cell type identity to dynamic transitions in 
cellular phenotypes in space and time 
First published pilot datasets by members of the HCA initiative on healthy and diseased human lung ​(48,                 
53, 95) have established marker signatures of the main cell types in human lungs. These datasets were                 
derived from both healthy donor and diseased tissue (e.g. Asthma, ILD/IPF). Of note, in many cases cell                 
type specific clusters do not align well in high dimensional gene expression space, even if only healthy                 
donor controls are compared. This is typically discussed as sample specific `batch´ effects, however very               
likely also represents true biological variation between donors. The human lung is exposed to a great                
variety of environmental perturbations (e.g. infections, allergens, nanoparticles, smoke) and individual           
donors will differ in predispositions to react to these environmental insults (e.g. genetics, age). Thus, the                
observed inter-individual variation of cellular phenotypes will partially represent specific cellular           
responses to perturbations and subsequent return to normal homeostasis. Data acquired for the Human              
Lung Cell Atlas will enable to generate predictive models of cell type specific gene regulation. To                
experimentally test these models we propose that it will be necessary to develop and employ human ex                 




Figure 2 . (a) Surfactant protein C (SFTPC) positive AT2 cell clusters are shown in a dimension reduced UMAP plot (left upper                      
and lower panel). The heatmap in the right panel shows constitutive genes defining AT2 cell type identity across 8 healthy                    
donors, and clusters of genes that have been found to significantly differ between AT2 cells of different individuals. ​(b) Data                    
collected in the Human Lung Cell Atlas project will be used to define cell type identity in a ​hierarchical approach ​, which defines                      
cell type by similarity metrics of their marker genes across many individuals. Based on these cell type identities and observed                    
variation in facultative gene modules within the different cell types we will generate predictive models of gene regulation that                   
can be experimentally tested. These models will put (disease-) genes in context of their cell type specific `gene regulatory                   
environments´ and predict both the appearance of constitutive and facultative gene modules as a function of time and space as                    
occurring during lung development or regenerative and immune responses. 
 
